Dr. Reddys Laboratories Ltd.
BSE: 500124 | NSE: DRREDDY
Mid Cap | Pharmaceuticals & Drugs
1350.20
11.70
(0.87%)
< Home
< Back
Dr. Reddys Laboratories Ltd. News
>>
Dr. Reddy’s Lab trades in green on the BSE
>>
Dr. Reddy's Lab completes divestment of Zembrace Symtouch, Tosymra to Upsher-Smith
>>
Dr. Reddy’s Laboratories informs about press release
>>
Dr Reddy's Lab launches Fexofenadine HCI, Pseudoephedrine HCI Extended-Release Tablets
>>
USFDA completes audit at Dr. Reddy’s Laboratories’ Hyderabad plant
>>
Dr Reddy's Lab gains on launching OTC store-brand equivalent of Mucinex D Extended Release Tablets
>>
Dr Reddy's Lab launches OTC store-brand equivalent of Mucinex D Extended Release Tablets
>>
Dr Reddy's Laboratories planning to launch value-added drugs in US
>>
Dr. Reddy’s Laboratories submits press release
>>
Dr. Reddy's launches Carboprost Tromethamine Injection USP
<<
<
67
68
69
...145
>
>>